{"pmid":32417316,"title":"Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.","text":["Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.","J Infect","Shi, Li","Wang, Ying","Wang, Yadong","Duan, Guangcai","Yang, Haiyan","32417316"],"journal":"J Infect","authors":["Shi, Li","Wang, Ying","Wang, Yadong","Duan, Guangcai","Yang, Haiyan"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417316","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jinf.2020.05.013","keywords":["covid-19","dyspnea","fever","mortality","risk factor"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667058206760763393,"score":9.490897,"similar":[{"pmid":32421539,"title":"Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography.","text":["Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography.","Patients with Coronavirus Disease 2019 (COVID-19) often have clinical characteristics, such as chest tightness and dyspnea. Continuous, unresolved dyspnea often indicates the progression of lung lesions. The mechanism that underlies the chest distress and dyspnea in patients with COVID-19 is still unclear. Chest CT has a higher sensitivity and can play an essential role in the diagnosis and treatment of the disease. However, our clinical observations showed that although some patients had significant chest distress and dyspnea, the lesions that were observed in the lungs during computed tomography were milder and not completely consistent with clinical symptoms. We analyzed the clinical characteristics, laboratory test results, and imaging findings of these patients. We found that extensive inflammation of the bilateral and respiratory bronchioles in patients with COVID-19 due to excessive activation of proinflammatory cytokines and chemotactic aggregation of T-lymphocytes at the site of inflammation are possible mechanisms underlying chest distress and dyspnea in patients with COVID-19. Short-time and lose-dose use of corticosteroid may be helpful to treat chest tightness and dyspnea in mild COVID-19 patients. Through this study, we aimed to improve our understanding of the pathogenesis of COVID-19.","Respir Med","Nie, Shuke","Han, Shoumeng","Ouyang, Huangqing","Zhang, Zhan","32421539"],"abstract":["Patients with Coronavirus Disease 2019 (COVID-19) often have clinical characteristics, such as chest tightness and dyspnea. Continuous, unresolved dyspnea often indicates the progression of lung lesions. The mechanism that underlies the chest distress and dyspnea in patients with COVID-19 is still unclear. Chest CT has a higher sensitivity and can play an essential role in the diagnosis and treatment of the disease. However, our clinical observations showed that although some patients had significant chest distress and dyspnea, the lesions that were observed in the lungs during computed tomography were milder and not completely consistent with clinical symptoms. We analyzed the clinical characteristics, laboratory test results, and imaging findings of these patients. We found that extensive inflammation of the bilateral and respiratory bronchioles in patients with COVID-19 due to excessive activation of proinflammatory cytokines and chemotactic aggregation of T-lymphocytes at the site of inflammation are possible mechanisms underlying chest distress and dyspnea in patients with COVID-19. Short-time and lose-dose use of corticosteroid may be helpful to treat chest tightness and dyspnea in mild COVID-19 patients. Through this study, we aimed to improve our understanding of the pathogenesis of COVID-19."],"journal":"Respir Med","authors":["Nie, Shuke","Han, Shoumeng","Ouyang, Huangqing","Zhang, Zhan"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32421539","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.rmed.2020.105951","keywords":["covid-19","chest ct","chest tightness","corticosteroid use","dyspnea"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1667254896781426689,"score":84.984215},{"pmid":32483458,"pmcid":"PMC7255028","title":"Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.","text":["Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.","Background: The risk factors for adverse events of Coronavirus Disease-19 (COVID-19) have not been well described. We aimed to explore the predictive value of clinical, laboratory and CT imaging characteristics on admission for short-term outcomes of COVID-19 patients. Methods: This multicenter, retrospective, observation study enrolled 703 laboratory-confirmed COVID-19 patients admitted to 16 tertiary hospitals from 8 provinces in China between January 10, 2020 and March 13, 2020. Demographic, clinical, laboratory data, CT imaging findings on admission and clinical outcomes were collected and compared. The primary endpoint was in-hospital death, the secondary endpoints were composite clinical adverse outcomes including in-hospital death, admission to intensive care unit (ICU) and requiring invasive mechanical ventilation support (IMV). Multivariable Cox regression, Kaplan-Meier plots and log-rank test were used to explore risk factors related to in-hospital death and in-hospital adverse outcomes. Results: Of 703 patients, 55 (8%) developed adverse outcomes (including 33 deceased), 648 (92%) discharged without any adverse outcome. Multivariable regression analysis showed risk factors associated with in-hospital death included >/= 2 comorbidities (hazard ratio [HR], 6.734; 95% CI; 3.239-14.003, p < 0.001), leukocytosis (HR, 9.639; 95% CI, 4.572-20.321, p < 0.001), lymphopenia (HR, 4.579; 95% CI, 1.334-15.715, p = 0.016) and CT severity score > 14 (HR, 2.915; 95% CI, 1.376-6.177, p = 0.005) on admission, while older age (HR, 2.231; 95% CI, 1.124-4.427, p = 0.022), >/= 2 comorbidities (HR, 4.778; 95% CI; 2.451-9.315, p < 0.001), leukocytosis (HR, 6.349; 95% CI; 3.330-12.108, p < 0.001), lymphopenia (HR, 3.014; 95% CI; 1.356-6.697, p = 0.007) and CT severity score > 14 (HR, 1.946; 95% CI; 1.095-3.459, p = 0.023) were associated with increased odds of composite adverse outcomes. Conclusion: The risk factors of older age, multiple comorbidities, leukocytosis, lymphopenia and higher CT severity score could help clinicians identify patients with potential adverse events.","Theranostics","Xu, Peng Peng","Tian, Rong Hua","Luo, Song","Zu, Zi Yue","Fan, Bin","Wang, Xi Ming","Xu, Kai","Wang, Jiang Tao","Zhu, Juan","Shi, Ji Chan","Chen, Feng","Wan, Bing","Yan, Zhi Han","Wang, Rong Pin","Chen, Wen","Fan, Wen Hui","Zhang, Can","Lu, Meng Jie","Sun, Zhi Yuan","Zhou, Chang Sheng","Zhang, Li Na","Xia, Fei","Qi, Li","Zhang, Wei","Zhong, Jing","Liu, Xiao Xue","Zhang, Qi Rui","Lu, Guang Ming","Zhang, Long Jiang","32483458"],"abstract":["Background: The risk factors for adverse events of Coronavirus Disease-19 (COVID-19) have not been well described. We aimed to explore the predictive value of clinical, laboratory and CT imaging characteristics on admission for short-term outcomes of COVID-19 patients. Methods: This multicenter, retrospective, observation study enrolled 703 laboratory-confirmed COVID-19 patients admitted to 16 tertiary hospitals from 8 provinces in China between January 10, 2020 and March 13, 2020. Demographic, clinical, laboratory data, CT imaging findings on admission and clinical outcomes were collected and compared. The primary endpoint was in-hospital death, the secondary endpoints were composite clinical adverse outcomes including in-hospital death, admission to intensive care unit (ICU) and requiring invasive mechanical ventilation support (IMV). Multivariable Cox regression, Kaplan-Meier plots and log-rank test were used to explore risk factors related to in-hospital death and in-hospital adverse outcomes. Results: Of 703 patients, 55 (8%) developed adverse outcomes (including 33 deceased), 648 (92%) discharged without any adverse outcome. Multivariable regression analysis showed risk factors associated with in-hospital death included >/= 2 comorbidities (hazard ratio [HR], 6.734; 95% CI; 3.239-14.003, p < 0.001), leukocytosis (HR, 9.639; 95% CI, 4.572-20.321, p < 0.001), lymphopenia (HR, 4.579; 95% CI, 1.334-15.715, p = 0.016) and CT severity score > 14 (HR, 2.915; 95% CI, 1.376-6.177, p = 0.005) on admission, while older age (HR, 2.231; 95% CI, 1.124-4.427, p = 0.022), >/= 2 comorbidities (HR, 4.778; 95% CI; 2.451-9.315, p < 0.001), leukocytosis (HR, 6.349; 95% CI; 3.330-12.108, p < 0.001), lymphopenia (HR, 3.014; 95% CI; 1.356-6.697, p = 0.007) and CT severity score > 14 (HR, 1.946; 95% CI; 1.095-3.459, p = 0.023) were associated with increased odds of composite adverse outcomes. Conclusion: The risk factors of older age, multiple comorbidities, leukocytosis, lymphopenia and higher CT severity score could help clinicians identify patients with potential adverse events."],"journal":"Theranostics","authors":["Xu, Peng Peng","Tian, Rong Hua","Luo, Song","Zu, Zi Yue","Fan, Bin","Wang, Xi Ming","Xu, Kai","Wang, Jiang Tao","Zhu, Juan","Shi, Ji Chan","Chen, Feng","Wan, Bing","Yan, Zhi Han","Wang, Rong Pin","Chen, Wen","Fan, Wen Hui","Zhang, Can","Lu, Meng Jie","Sun, Zhi Yuan","Zhou, Chang Sheng","Zhang, Li Na","Xia, Fei","Qi, Li","Zhang, Wei","Zhong, Jing","Liu, Xiao Xue","Zhang, Qi Rui","Lu, Guang Ming","Zhang, Long Jiang"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32483458","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7150/thno.46833","keywords":["covid-19","coronavirus","mortality","pneumonia","risk factor"],"locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668532114890424320,"score":84.89478},{"pmid":32406952,"title":"Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.","text":["Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.","BACKGROUND: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic rapidly. Most of the literature showed that the elevated liver enzymes in COVID-19 are of little clinical significance. Lower albumin level is seen in severe COVID-19 and is not parallel to the changes in ALT and AST levels. We aimed to explore the impact of hypoalbuminemia in COVID-19. METHODS: This retrospective cohort study included adult patients with confirmed COVID-19. The relationship between hypoalbuminemia and death was studied using binary logistic analysis. RESULTS: A total of 299 adult patients were included, 160 (53.5%) were males and the average age was 53.4 +/- 16.7 years. The median time from the onset of illness to admission was 3 days (interquartile ranges 2-5). Approximately one-third of patients had comorbidities. Hypoalbuminemia (<35g/L) was found in 106 (35.5%) patients. The difference in albumin was considerable between survivors and non-survivors (37.6 +/- 6.2 vs. 30.5 +/- 4.0, P < 0.001). Serum albumin level was inversely correlated to white blood cell (r = -0.149, P = 0.01) and neutrophil to lymphocyte ratio (r = -0.298, P <0.001). Multivariate analysis showed the presence of comorbidities (OR = 6.816, 95%CI: 1.361-34.133), lymphopenia (OR = 13.130, 95%CI: 1.632-105.658) and hypoalbuminemia (OR = 6.394, 95%CI: 1.315-31.092) were independent predictive factors for mortality. CONCLUSIONS: Hypoalbuminemia was associated with the outcome of COVID-19. The potential therapeutic value of albumin infusion in COVID-19 should be further explored at the earliest. This article is protected by copyright. All rights reserved.","J Med Virol","Huang, Jiaofeng","Cheng, Aiguo","Kumar, Rahul","Fang, Yingying","Chen, Gongping","Zhu, Yueyong","Lin, Su","32406952"],"abstract":["BACKGROUND: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic rapidly. Most of the literature showed that the elevated liver enzymes in COVID-19 are of little clinical significance. Lower albumin level is seen in severe COVID-19 and is not parallel to the changes in ALT and AST levels. We aimed to explore the impact of hypoalbuminemia in COVID-19. METHODS: This retrospective cohort study included adult patients with confirmed COVID-19. The relationship between hypoalbuminemia and death was studied using binary logistic analysis. RESULTS: A total of 299 adult patients were included, 160 (53.5%) were males and the average age was 53.4 +/- 16.7 years. The median time from the onset of illness to admission was 3 days (interquartile ranges 2-5). Approximately one-third of patients had comorbidities. Hypoalbuminemia (<35g/L) was found in 106 (35.5%) patients. The difference in albumin was considerable between survivors and non-survivors (37.6 +/- 6.2 vs. 30.5 +/- 4.0, P < 0.001). Serum albumin level was inversely correlated to white blood cell (r = -0.149, P = 0.01) and neutrophil to lymphocyte ratio (r = -0.298, P <0.001). Multivariate analysis showed the presence of comorbidities (OR = 6.816, 95%CI: 1.361-34.133), lymphopenia (OR = 13.130, 95%CI: 1.632-105.658) and hypoalbuminemia (OR = 6.394, 95%CI: 1.315-31.092) were independent predictive factors for mortality. CONCLUSIONS: Hypoalbuminemia was associated with the outcome of COVID-19. The potential therapeutic value of albumin infusion in COVID-19 should be further explored at the earliest. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Huang, Jiaofeng","Cheng, Aiguo","Kumar, Rahul","Fang, Yingying","Chen, Gongping","Zhu, Yueyong","Lin, Su"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406952","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/jmv.26003","keywords":["covid-19","hypoalbuminemia","mortality","prediction","risk factor"],"locations":["lymphopenia","Hypoalbuminemia"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666802845532291072,"score":80.8266},{"pmid":32422233,"title":"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York.","text":["Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York.","BACKGROUND & AIMS: New York is the current epicenter of Coronavirus disease 2019 (COVID-19) pandemic. The underrepresented minorities, where the prevalence of obesity is higher, appear to be affected disproportionately. Our objectives were to assess the characteristics and early outcomes of patients hospitalized with COVID-19 in the Bronx and investigate whether obesity is associated with worse outcomes independently from age, gender and other comorbidities. METHODS: This retrospective study included the first 200 patients admitted to a tertiary medical center with COVID-19. The electronic medical records were reviewed at least three weeks after admission. The primary endpoint was in-hospital mortality. RESULTS: 200 patients were included (female sex: 102, African American: 102). The median BMI was 30 kg/m(2). The median age was 64 years. Hypertension (76%), hyperlipidemia (46.2%), and diabetes (39.5%) were the three most common comorbidities. Fever (86%), cough (76.5%), and dyspnea (68%) were the three most common symptoms. 24% died during hospitalization (BMI<25 kg/m(2): 31.6%, BMI 25-34 kg/m(2): 17.2%, BMI>/=35 kg/m(2): 34.8%, p= 0.03). Increasing age (analyzed in quartiles), male sex, BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2)), heart failure, CAD, and CKD or ESRD were found to have a significant univariate association with mortality. The multivariate analysis demonstrated that BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2), OR: 3.78; 95% CI: 1.45 - 9.83; p=0.006), male sex (OR: 2.74; 95% CI: 1.25 - 5.98; p=0.011) and increasing age (analyzed in quartiles, OR: 1.73; 95% CI: 1.13 - 2.63; p=0.011) were independently associated with higher in-hospital mortality. Similarly, age, male sex, BMI>/=35 kg/m(2) and current or prior smoking were significant predictors for increasing oxygenation requirements in the multivariate analysis, while male sex, age and BMI>/=35 kg/m(2) were significant predictors in the multivariate analysis for the outcome of intubation. CONCLUSIONS: In this cohort of hospitalized patients with COVID-19 in a minority-predominant population, severe obesity, increasing age, and male sex were independently associated with higher in-hospital mortality and in general worse in-hospital outcomes.","Metabolism","Palaiodimos, Leonidas","Kokkinidis, Damianos G","Li, Weijia","Karamanis, Dimitrios","Ognibene, Jennifer","Arora, Shitij","Southern, William N","Mantzoros, Christos S","32422233"],"abstract":["BACKGROUND & AIMS: New York is the current epicenter of Coronavirus disease 2019 (COVID-19) pandemic. The underrepresented minorities, where the prevalence of obesity is higher, appear to be affected disproportionately. Our objectives were to assess the characteristics and early outcomes of patients hospitalized with COVID-19 in the Bronx and investigate whether obesity is associated with worse outcomes independently from age, gender and other comorbidities. METHODS: This retrospective study included the first 200 patients admitted to a tertiary medical center with COVID-19. The electronic medical records were reviewed at least three weeks after admission. The primary endpoint was in-hospital mortality. RESULTS: 200 patients were included (female sex: 102, African American: 102). The median BMI was 30 kg/m(2). The median age was 64 years. Hypertension (76%), hyperlipidemia (46.2%), and diabetes (39.5%) were the three most common comorbidities. Fever (86%), cough (76.5%), and dyspnea (68%) were the three most common symptoms. 24% died during hospitalization (BMI<25 kg/m(2): 31.6%, BMI 25-34 kg/m(2): 17.2%, BMI>/=35 kg/m(2): 34.8%, p= 0.03). Increasing age (analyzed in quartiles), male sex, BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2)), heart failure, CAD, and CKD or ESRD were found to have a significant univariate association with mortality. The multivariate analysis demonstrated that BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2), OR: 3.78; 95% CI: 1.45 - 9.83; p=0.006), male sex (OR: 2.74; 95% CI: 1.25 - 5.98; p=0.011) and increasing age (analyzed in quartiles, OR: 1.73; 95% CI: 1.13 - 2.63; p=0.011) were independently associated with higher in-hospital mortality. Similarly, age, male sex, BMI>/=35 kg/m(2) and current or prior smoking were significant predictors for increasing oxygenation requirements in the multivariate analysis, while male sex, age and BMI>/=35 kg/m(2) were significant predictors in the multivariate analysis for the outcome of intubation. CONCLUSIONS: In this cohort of hospitalized patients with COVID-19 in a minority-predominant population, severe obesity, increasing age, and male sex were independently associated with higher in-hospital mortality and in general worse in-hospital outcomes."],"journal":"Metabolism","authors":["Palaiodimos, Leonidas","Kokkinidis, Damianos G","Li, Weijia","Karamanis, Dimitrios","Ognibene, Jennifer","Arora, Shitij","Southern, William N","Mantzoros, Christos S"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422233","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.metabol.2020.154262","keywords":["bronx","covid-19","new york","sars-cov-2","coronavirus","mortality","obesity","pandemic","risk factor"],"locations":["New York","Bronx","African American","hyperlipidemia","Bronx","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667159284600799232,"score":79.88628},{"pmid":32345749,"title":"Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic.","text":["Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic.","Clin J Am Soc Nephrol","Gleeson, Shana E","Formica, Richard N","Marin, Ethan P","32345749"],"journal":"Clin J Am Soc Nephrol","authors":["Gleeson, Shana E","Formica, Richard N","Marin, Ethan P"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32345749","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.2215/CJN.04510420","keywords":["covid-19","cough","cytomegalovirus infections","dyspnea","fever","outpatients","oxygen","pandemics","patient care","physical exertion","public health","sars virus","severe acute respiratory syndrome","immunosuppression","kidney transplantation","severe acute respiratory syndrome coronavirus 2","virology"],"topics":["Prevention"],"weight":1,"_version_":1666138495432785922,"score":79.64487}]}